Particulars (Rupees in Crores.) | Dec-2024 | Sept-2024 | Jun-2024 | Mar-2024 | Dec-2023 |
---|---|---|---|---|---|
Gross Sales | 219.16 | 217.77 | 211.78 | 177.75 | 166.79 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 219.16 | 217.77 | 211.78 | 177.75 | 166.79 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.21 | 2.97 | 3.65 | 5.66 | 5.38 |
Total Income | 223.37 | 220.74 | 215.44 | 183.41 | 172.17 |
Total Expenditure | 164.24 | 163.14 | 158.12 | 131.22 | 120.37 |
PBIDT | 59.13 | 57.6 | 57.32 | 52.19 | 51.8 |
Interest | 2.06 | 1.56 | 2.92 | 0.38 | 0.17 |
PBDT | 57.07 | 56.04 | 54.4 | 51.81 | 51.64 |
Depreciation | 16.91 | 15.95 | 11.44 | 7.7 | 7.85 |
Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 |
Tax | 11.21 | 10.57 | 13.61 | 4.29 | 14.04 |
Deferred Tax | -1.54 | -1.43 | -1.04 | 1.47 | 0.26 |
Reported Profit After Tax | 30.49 | 30.95 | 30.38 | 38.35 | 29.49 |
Minority Interest After NP | 0 | 0 | 0 | 0 | 0 |
Net Profit after Minority Interest | 30.49 | 30.95 | 30.38 | 38.35 | 29.49 |
Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 30.49 | 30.95 | 30.38 | 38.35 | 29.49 |
EPS (Unit Curr.) | 3.57 | 3.59 | 3.54 | 4.85 | 3.83 |
Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 |
Dividend (%) | 0 | 0 | 0 | 0 | 0 |
Equity | 96.35 | 85.85 | 85.85 | 85.85 | 85.85 |
Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 |
Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 |
PBIDTM(%) | 26.98 | 26.44 | 27.06 | 29.36 | 31.05 |
PBDTM(%) | 26.04 | 25.73 | 25.68 | 29.14 | 30.96 |
PATM(%) | 13.91 | 14.21 | 14.34 | 21.57 | 17.68 |
The QIP shares were at ₹595 per share which was 5% lower compared with the floor price of ₹626.
The strategic purchase intends to increase Yatharth Hospital's presence in the Delhi-NCR region, hence increasing its regional footprint.
This strategic acquisition is intended to strengthen Yatharth Hospital's presence in the Delhi-NCR region and expand its reach to serve a larger population.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.